{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vascular:pharmacology:pentoxifylline",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T15:00:00.000Z",
    "contributors": [
      "vascular-surgery-agent"
    ],
    "status": "enhanced",
    "copyright_compliance": "Original content based on general medical knowledge",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pharmacology",
    "type": "medication",
    "difficulty": "intermediate",
    "importance": "low",
    "board_yield": "MEDIUM"
  },
  "content": {
    "title": "Pentoxifylline",
    "definition": "Methylxanthine derivative that improves blood flow by increasing red blood cell deformability and decreasing blood viscosity, approved for treatment of intermittent claudication.",
    "mechanism_of_action": {
      "primary": [
        "Increases red blood cell flexibility/deformability",
        "Decreases blood viscosity",
        "Inhibits platelet aggregation"
      ],
      "secondary": [
        "Phosphodiesterase inhibition",
        "Increased cAMP levels",
        "Anti-inflammatory effects"
      ]
    },
    "indications": {
      "approved": "Intermittent claudication from chronic occlusive arterial disease",
      "off_label": [
        "Venous leg ulcers",
        "Radiation-induced fibrosis",
        "Alcoholic hepatitis"
      ]
    },
    "dosing": {
      "standard": "400 mg three times daily",
      "with_meals": "Recommended to reduce GI side effects",
      "renal_adjustment": "May need dose reduction in CKD"
    },
    "efficacy": {
      "claudication": "Modest benefit in walking distance",
      "vs_cilostazol": "Less effective than cilostazol",
      "guideline_status": "Weak recommendation, may be considered if cilostazol contraindicated"
    },
    "side_effects": {
      "common": [
        "Nausea",
        "Dizziness",
        "Headache",
        "Dyspepsia"
      ],
      "serious": "Rare"
    },
    "contraindications": [
      "Recent cerebral or retinal hemorrhage",
      "Intolerance to methylxanthines (caffeine, theophylline)"
    ],
    "terminology": {
      "snomed_ct": "387245006",
      "icd_10": "Z79.899"
    },
    "statement": "Pentoxifylline is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pharmacology that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Pentoxifylline helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Pentoxifylline include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Pentoxifylline."
    }
  },
  "pedagogical": {
    "learning_objectives": [
      "Describe pentoxifylline mechanism of action",
      "Compare efficacy to cilostazol",
      "Identify appropriate candidates"
    ],
    "clinical_pearls": [
      "Cilostazol is superior to pentoxifylline",
      "Modest benefit at best for claudication",
      "Consider if cilostazol contraindicated (heart failure)"
    ]
  },
  "relationships": {
    "broader": [
      "vascular:pharmacology:claudication-medications"
    ],
    "related": [
      "vascular:pharmacology:cilostazol",
      "vascular:pad:claudication"
    ],
    "narrower": []
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Pentoxifylline. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}